Fig. 3From: Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis of randomized controlled trials and real-world evidence-based assessmentsThe relationship of overall adverse events between the anti-IL-5 treatment group and the control group for patients with eosinophilic asthmaBack to article page